These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8485008)

  • 1. [Risk factors for the progression of chronic kidney failure].
    Maschio G; Oldrizzi L; Rugiu C
    Ann Ital Med Int; 1993; 8(1):35-7. PubMed ID: 8485008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
    Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H
    Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of chronic kidney disease in children with vesicoureteral reflux: the North American Pediatric Renal Trials Collaborative Studies Database.
    Novak TE; Mathews R; Martz K; Neu A
    J Urol; 2009 Oct; 182(4 Suppl):1678-81. PubMed ID: 19692051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression of chronic renal disease.
    Klahr S
    Nutrition; 1990; 6(3):207-12. PubMed ID: 2135999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective analysis of factors affecting the progression of chronic renal failure in adult polycystic kidney disease.
    Ahmed ER; Tashkandi MA; Nahrir S; Maulana A
    Saudi J Kidney Dis Transpl; 2006 Dec; 17(4):511-5. PubMed ID: 17186685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mechanism of progression of chronic renal failure and new treatment strategies].
    Litwin M
    Pol Merkur Lekarski; 2000 Apr; 8(46):301-2. PubMed ID: 10897662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between chronic kidney disease prevalence and end-stage renal disease risk.
    Hallan SI; Vikse BE
    Curr Opin Nephrol Hypertens; 2008 May; 17(3):286-91. PubMed ID: 18408480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial.
    Ishani A; Grandits GA; Grimm RH; Svendsen KH; Collins AJ; Prineas RJ; Neaton JD
    J Am Soc Nephrol; 2006 May; 17(5):1444-52. PubMed ID: 16611715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The progression of chronic renal disease: immunological, nutritional and intrinsic renal mechanisms.
    Drukker A
    Isr J Med Sci; 1997 Nov; 33(11):739-43. PubMed ID: 9434811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors in immunoglobulin-A nephropathy.
    Muthukumar T; Fernando ME; Jayakumar M
    J Assoc Physicians India; 2002 Nov; 50():1354-9. PubMed ID: 12583461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease.
    Hsu CY; McCulloch CE; Darbinian J; Go AS; Iribarren C
    Arch Intern Med; 2005 Apr; 165(8):923-8. PubMed ID: 15851645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors of renal failure progression two years prior to dialysis.
    Mazouz H; Kacso I; Ghazali A; El Esper N; Moriniere P; Makdassi R; Hardy P; Westeel PF; Achard JM; Pruna A; Fournier A
    Clin Nephrol; 1999 Jun; 51(6):355-66. PubMed ID: 10404696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hypertension in chronic kidney disease.
    Toto RD
    Semin Nephrol; 2005 Nov; 25(6):435-9. PubMed ID: 16298269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanisms of progression of glomerular sclerosis in chronic renal diseases in man].
    Garini G; Allegri L; Arisi L
    Ann Ital Med Int; 1989; 4(3):184-94. PubMed ID: 2702030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Non-immunological therapy in nephropathies leading to chronic renal failure and in post-transplant chronic renal dysfunction].
    Amore A; Camilla R; Rollino C; Avenatti E; Campolo F; Peruzzi L; Conti G; Coppo R
    G Ital Nefrol; 2008; 25 Suppl 44():53-63. PubMed ID: 19048587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of tubulointerstitial changes in progression of kidney function failure in patients with chronic glomerulonephritis (GN)].
    Idasiak-Piechocka I; Krzymański M
    Przegl Lek; 1996; 53(5):443-53. PubMed ID: 8754411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors affecting progression of renal insufficiency.
    Locatelli F; Manzoni C; Marcelli D
    Miner Electrolyte Metab; 1997; 23(3-6):301-5. PubMed ID: 9387138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression to renal failure.
    Topaloğlu R
    Turk J Pediatr; 2005; 47 Suppl():3-8. PubMed ID: 15884660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical course and prognostic factors in lupus nephropathy].
    Gamba G; Quintanilla L; del Bosque MD; Chew-Wong A; Correa-Rotter R
    Rev Invest Clin; 2000; 52(4):397-405. PubMed ID: 11061101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.